Graham Kelly made sure that the clinical trial program logistics for DARRT, IONIC and CEP were in place before his transition to "consultant" took effect. In his new role, I expect him to be able to concentrate on patent matters - which is virtually a full-time job - and major projects such as the HIMR License.
Noxopharm represents his life's work, so there is no way Graham will have taken this step if he thought the Company would suffer. This change means that Noxopharm will have a new 'face' as CEO, and that Graham will have more time to focus on big-ticket items.
- Forums
- ASX - By Stock
- Ann: Noxopharm Announces Leadership Transition
Graham Kelly made sure that the clinical trial program logistics...
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
8.0¢ |
Change
0.010(14.3%) |
Mkt cap ! $23.37M |
Open | High | Low | Value | Volume |
7.0¢ | 8.0¢ | 7.0¢ | $4.207K | 56.02K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 118527 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
8.0¢ | 4999 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 118527 | 0.075 |
2 | 14000 | 0.067 |
1 | 141114 | 0.066 |
1 | 100000 | 0.064 |
1 | 77000 | 0.062 |
Price($) | Vol. | No. |
---|---|---|
0.080 | 4999 | 1 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 25689 | 3 |
0.092 | 5555 | 1 |
Last trade - 16.10pm 21/06/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online